These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33994342)

  • 21. Monte Carlo dosimetry of high dose rate gynecologic interstitial brachytherapy.
    Desbiens M; D'Amours M; Afsharpour H; Verhaegen F; Lavallée MC; Thibault I; Vigneault É; Beaulieu L
    Radiother Oncol; 2013 Dec; 109(3):425-9. PubMed ID: 24135700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implementation, logistics and workflow guide for MRI image based interstitial HDR brachytherapy for gynecological cancers.
    Zhang H; Donnelly ED; Strauss JB; Kang Z; Gopalakrishnan M; Lee PC; Khelashvili G; Nair CK; Lee BH; Sathiaseelan V
    J Appl Clin Med Phys; 2019 Nov; 20(11):37-49. PubMed ID: 31600015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Needle displacement during HDR brachytherapy in the treatment of prostate cancer.
    Damore SJ; Syed AM; Puthawala AA; Sharma A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1205-11. PubMed ID: 10725633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient-based high-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Dyk PT; Richardson S; Badiyan SN; Schwarz JK; Esthappan J; Garcia-Ramirez JL; Grigsby PW
    Brachytherapy; 2015; 14(2):231-7. PubMed ID: 25556865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
    Schindel J; Muruganandham M; Pigge FC; Anderson J; Kim Y
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):387-93. PubMed ID: 23433797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D image-based adapted high-dose-rate brachytherapy in cervical cancer with and without interstitial needles: measurement of applicator shift between imaging and dose delivery.
    Karlsson L; Thunberg P; With A; Mordhorst LB; Persliden J
    J Contemp Brachytherapy; 2017 Feb; 9(1):52-58. PubMed ID: 28344604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of fluoroscopy to guide needle placement in interstitial gynecological brachytherapy.
    Nag S; Martínez-Monge R; Ellis R; Lewandowski G; Vacarello L; Boutselis JG; Copeland L
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):415-20. PubMed ID: 9457830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose--volume histogram analysis.
    Thibault I; Lavallée MC; Aubin S; Laflamme N; Vigneault E
    Brachytherapy; 2012; 11(3):181-91. PubMed ID: 21862418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of an automatic interstitial catheter digitization tool for adaptive high-dose-rate brachytherapy.
    Dise J; Liang X; Scheuermann J; Anamalayil S; Mesina C; Lin LL; Teo BK
    Brachytherapy; 2015; 14(5):619-25. PubMed ID: 26073225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prototype open-ended multichannel intracavitary-interstitial hybrid applicator for gynecological high-dose-rate brachytherapy.
    Tien CJ; Chen ZJ
    Radiol Phys Technol; 2020 Jun; 13(2):187-194. PubMed ID: 32424632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily computed tomography measurement of needle applicator displacement during high-dose-rate interstitial brachytherapy for previously untreated uterine cervical cancer.
    Mikami M; Yoshida K; Takenaka T; Yamazaki H; Kotsuma T; Yoshida M; Aramoto K; Yamada S; Ban C; Tanaka E; Honda K
    Brachytherapy; 2011; 10(4):318-24. PubMed ID: 21236738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
    Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
    Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fast inverse treatment planning strategy facilitating optimized catheter selection in image-guided high-dose-rate interstitial gynecologic brachytherapy.
    Guthier CV; Damato AL; Hesser JW; Viswanathan AN; Cormack RA
    Med Phys; 2017 Dec; 44(12):6117-6127. PubMed ID: 28921538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability of marker-based rectal dose evaluation in HDR cervical brachytherapy.
    Wang Z; Jaggernauth W; Malhotra HK; Podgorsak MB
    Med Dosim; 2010; 35(4):269-73. PubMed ID: 19944586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and clinical implementation of simple needle attachment post placement interstitial template (SNAPP-IT) enabling a shorter, more direct needle path while preserving tumor visualization.
    Baniel CC; Hui C; Franco PA; Niedermayr T; Kidd EA
    Brachytherapy; 2024; 23(2):149-153. PubMed ID: 38160101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing the impact of adaptive planning on image-guided perineal interstitial brachytherapy for gynecologic malignancies.
    Gladwish A; Ravi A; Barbera L; Mendez L; Davidson M; D'Alimonte L; D'Souza D; Wronski M; Leung E
    Brachytherapy; 2018; 17(2):352-359. PubMed ID: 29241705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.
    Lee LJ; Damato AL; Viswanathan AN
    Brachytherapy; 2013; 12(4):303-10. PubMed ID: 23491023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion.
    Kertzscher G; Andersen CE; Siebert FA; Nielsen SK; Lindegaard JC; Tanderup K
    Radiother Oncol; 2011 Sep; 100(3):456-62. PubMed ID: 21963285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of needle displacement in multifraction high-dose-rate prostate brachytherapy: A prospective volumetric analysis and technical considerations.
    Peddada AV; Blasi OC; White GA; Monroe AT; Jennings SB; Gibbs GL
    Pract Radiat Oncol; 2015; 5(4):228-37. PubMed ID: 25543199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.